IRIS

Octreotide SC depot in patients with acromegaly and functioning neuroendocrine tumors: a phase 2, multicenter study / Pavel, Marianne; Borson-Chazot, Françoise; Cailleux, Anne; Hörsch, Dieter; Lahner, Harald; Pivonello, Rosario; Tauchmanova, Libuse; Darstein, Christelle; Olsson, Håkan; Tiberg, Fredrik; Ferone, Diego. - In: CANCER CHEMOTHERAPY AND PHARMACOLOGY. - ISSN 0344-5704. - (2019). [10.1007/s00280-018-3734-1]

Octreotide SC depot in patients with acromegaly and functioning neuroendocrine tumors: a phase 2, multicenter study

Pivonello, Rosario;Tauchmanova, Libuse;
2019
2019
Octreotide SC depot in patients with acromegaly and functioning neuroendocrine tumors: a phase 2, multicenter study / Pavel, Marianne; Borson-Chazot, Françoise; Cailleux, Anne; Hörsch, Dieter; Lahner, Harald; Pivonello, Rosario; Tauchmanova, Libuse; Darstein, Christelle; Olsson, Håkan; Tiberg, Fredrik; Ferone, Diego. - In: CANCER CHEMOTHERAPY AND PHARMACOLOGY. - ISSN 0344-5704. - (2019). [10.1007/s00280-018-3734-1]
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/738984
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 18
  • ???jsp.display-item.citation.isi??? 15
social impact